Christopher Keenan Email and Phone Number
Christopher Keenan work email
- Valid
- Valid
- Valid
- Valid
Christopher Keenan personal email
- Valid
- Valid
Christopher Keenan phone numbers
25+ year professional of increasing responsibilities in investor relations, corporate/ financial/ internal communications, media/ public relations, corporate financing and marketing. Skilled communicator who has executed successful investor and media relations plans for multiple companies. Clear ability to disseminate highly scientific terminology and complex concepts to mainstream audiences. Background ranging from large to micro cap companies within the biotechnology (drug, medical device, and instrument), specialty pharmaceutical and pharmaceutical industries.In previous roles, I have established the IR function and in doing so have increased sell-side coverage, attracted multiple new investors, engaged high level media opportunities, led branding/re-branding strategies and executed several companies first R&D Investor Day.Specialties: Investor surveillance/ targeting/ outreach, media/ public relations, shareholder relationship management, crisis management, road show execution, shareholder communications, marketing, corporate branding, execution of corporate marketing/ trade shows/ advertising, government affairs, sales force communications, hostile takeover, shareholder activism.
Pliant Therapeutics
View-
Vice President, Investor Relations & Corporate CommunicationsPliant Therapeutics Oct 2020 - PresentSouth San Francisco, California, Us
-
Vice President, Investor Relations & Corporate CommunicationsCytomx Therapeutics Apr 2018 - Oct 2020South San Francisco, Ca, UsEstablished internal IR function. Executed the Company’s first R&D Day, managed Sell-Side coverage (11 at height), implemented multiple investor events around clinical milestone events, assisted in execution of first follow-on offering netting $140M, recipient of 2019 CEO Vision Award for production of CytomX patient video. -
Vice President, Investor Relations & Corporate Communications, Depomed, Inc.Depomed, Inc. Jul 2015 - Mar 2018Newark, Ca, Us[Company relocation to Chicago Spring 2018] Led IR and Corporate Communications functions for 6 product commercial-stage company. Executed the Company’s first R&D Day, increased Sell-Side coverage (13 at height), and served as a member of 5 person core team that executed initiatives surrounding the hostile takeover attempt and subsequent shareholder activist situations. Assisted external public relations groups overseeing the company’s 6 marketed drugs in various internal and external messaging projects. -
Senior Director, Investor Relations & Corporate Communications, Peregrine PharmaceuticalsAvid Bioservices Jan 2012 - Jun 2015Tustin, California, Us(FKA Peregrine Pharmaceuticals, Inc) Oversaw IR and CC functions with management of two managers of Corporate Communications/ Marketing. Responsible for external and internal communications, areas of public relations, advertising and corporate marketing strategy. Served as primary interface with current investor base as well as targeted institutional Wall Street factions. -
Director, Investor And Media RelationsCytokinetics, Inc. Oct 2006 - Jan 2012South San Francisco, California, UsEstablished internal IR function. Oversaw all investor communications including quarterly reporting, Annual Report design and execution, investor targeting and surveillance, sell-side and buy-side analyst interface, presentations to Board of Directors and all of media relations. Executed the company's first R&D Investor Day. -
Director, Investor Relations & Corporate CommunicationsAradigm Corporation Apr 2002 - Sep 2006Served as sole interface for primarily retail-held investor base. Oversaw brainstorming and execution of all corporate communication strategies including financial announcements, IR webcasts, internal communications and media relations. Responsible for company's first print advertisement, trade shows/booth design and attendance and creation of marketing collateral material. Worked collaboratively with corporate partner Novo Nordisk.
-
Director, Corporate CommuncationsPerkinelmer Inc. May 2000 - Feb 2001Shelton, Ct, UsServed as corporate interface on Corporate Communications issues for four business units (Optoelectronics, Instruments, Fluid Sciences, Life Sciences). Oversaw the launch and integration of what is now PerkinElmer NEN® (New England Nuclear). Secured highly visible press for CEO including multiple CNBC shows, Bloomberg News, print features in The Boston Globe (Sunday Business Cover Page) and Forbes and managed the CEO's 2000 Harvard Business Review feature. -
Associate Director, Investor Relations And Corporate Communications, Isis PharmaceuticalsIonis Pharmaceuticals, Inc. Mar 1997 - Apr 2000Carlsbad, Ca, Us(FKA Isis Pharmaceuticals) Served as one of the corporate designated intermediaries between retail and institutional shareholders as well as corporate partners and the company. Assisted in execution of company materials including public announcements, scientific collateral and the Annual Shareholder Scientific Forum/ Annual Meeting. Responsible for managing outside public relations firms and execution of a media relations strategy. -
Senior Research AssociateThe Weinberg Group Aug 1990 - Mar 1997Washington, Dc, UsAssisted clients in all stages of a liability crisis, from the early phases of regulatory and legislative scrutiny through the litigation battles and advising on end-stage settlement strategies. Provided research in support of complex scientific and financial issues central to resolving high-profile disputes that impacted the client's products and corporate image. These included scientific literature review and synopsis, trial expert identification and recruitment, interactions with U.S. and European regulatory bodies and the execution and management of strategic due diligence programs in response to a Consent Decree from the U.S. Department of Justice. Issues worked on involved: Alcoholic beverages, dioxins, tobacco, Lone Star Steel litigation, breast implants and multiple medical device based litigations, asbestos and food labelling and additives.
Christopher Keenan Skills
Christopher Keenan Education Details
-
Kenyon CollegeEnglish
Frequently Asked Questions about Christopher Keenan
What company does Christopher Keenan work for?
Christopher Keenan works for Pliant Therapeutics
What is Christopher Keenan's role at the current company?
Christopher Keenan's current role is Experienced Biopharmaceutical Investor Relations and Communications Professional.
What is Christopher Keenan's email address?
Christopher Keenan's email address is r5****@****ail.com
What is Christopher Keenan's direct phone number?
Christopher Keenan's direct phone number is +141550*****
What schools did Christopher Keenan attend?
Christopher Keenan attended Kenyon College.
What skills is Christopher Keenan known for?
Christopher Keenan has skills like Public Relations, Marketing, Advertising, Crisis Management, Corporate Branding, Trade Shows, Investor Relations, Biotechnology, Corporate Communications, Strategic Planning, Crisis Communications, Strategic Communications.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial